Table 5.
Adjusted Risk of Major Adverse Event
Primary Analysis (not including death) | Secondary Analysis (including death) | |||
---|---|---|---|---|
Predictor | Odds Ratio (95% CI) | P value | Odds Ratio (95% CI) | P value |
Annual Volume | ||||
<150 | Reference | Reference | ||
150-<300 | 0.55 (0.35, 0.86) | 0.008 | 0.82 (0.59, 1.14) | 0.24 |
300-<500 | 0.62 (0.41, 0.95) | 0.03 | 0.73 (0.53, 1.01) | 0.06 |
≥500 | 0.52 (0.31, 0.90) | 0.02 | 0.78 (0.52, 1.15) | 0.21 |
Procedure-type risk group | ||||
1 | Reference | Reference | ||
2 | 1.31 (1.06, 1.62) | 0.01 | 1.86 (1.44, 2.39) | <0.001 |
3 | 1.57 (1.26, 1.96) | <0.001 | 1.76 (1.35, 2.31) | <0.001 |
4 | 2.03 (1.59, 2.61) | <0.001 | 2.03 (1.50, 2.77) | <0.001 |
Age | ||||
<30 days | Reference | Reference | ||
≥30 days to ≤1 year | 0.98 (0.77, 1.25) | 0.89 | 0.89 (0.71, 1.11) | 0.31 |
1≤18 years | 0.86 (0.66, 1.11) | 0.24 | 0.69 (0.55, 0.88) | 0.002 |
>18 years | 0.94 (0.69, 1.29) | 0.72 | 0.82 (0.62, 1.08) | 0.16 |
Genetic/Congenital condition | 1.05 (0.86, 1.28) | 0.64 | 1.36 (1.15, 1.59) | <0.001 |
History of CLD | 0.86 (0.67, 1.12) | 0.27 | 1.79 (1.49, 2.15) | <0.001 |
History of Renal Insufficiency | 2.32 (1.77, 3.04) | <0.001 | 3.16 (2.50, 4.01) | <0.001 |
Single Ventricle | 1.34 (1.15, 1.56) | <0.001 | 1.39 (1.22, 1.60) | <0.001 |
Pre-procedure sepsis | 1.43 (0.88, 2.31) | 0.15 | 1.50 (0.95, 2.38) | 0.08 |
Need for Inotropes | 1.75 (1.43, 2.14) | <0.001 | 2.58 (2.16, 3.08) | <0.001 |
Need for ECMO | 1.09 (0.77, 1.54) | 0.63 | 5.79 (4.22, 7.93) | <0.001 |
Need for LVAD | 0.81 (0.19, 3.43) | 0.77 | 2.97 (0.96, 9.25) | 0.06 |
Procedure Status | ||||
Elective | Reference | Reference | ||
Urgent | 2.14 (1.78, 2.58) | <0.001 | 2.99 (2.55, 3.50) | <0.001 |
Emergent | 3.51 (2.69, 4.57) | <0.001 | 4.42 (3.47, 5.63) | <0.001 |
Salvage | 5.85 (3.37, 10.14) | <0.001 | 21.80 (11.95, 39.79) | <0.001 |
Saturation <95% (non-SV) or <78% (SV) | ||||
No | Reference | Reference | ||
Yes | 1.13(0.96, 1.33) | 0.15 | 1.13 (0.98, 1.31) | 0.08 |
Missing | 1.11 (0.87, 1.41) | 0.39 | 1.00 (0.80, 1.26) | 0.97 |
MV Saturation <60% (non-SV) or <50% (SV) | ||||
No | Reference | Reference | ||
Yes | 1.80 (1.49, 2.18) | <0.001 | 1.85 (1.58, 2.18) | <0.001 |
Missing | 1.31 (1.04, 1.64) | 0.02 | 1.65 (1.35, 2.02) | <0.001 |
MPA Systolic Pressure ≥45 (non-SV) or MPA Mean Pressure ≥17mmHg (SV) | ||||
No | Reference | Reference | ||
Yes | 1.32 (1.09, 1.59) | 0.004 | 1.99 (1.71, 2.32) | <0.001 |
Missing | 1.42 (1.18, 1.71) | <0.001 | 1.27 (1.07, 1.51) | 0.005 |
Systemic Ventricular EDP ≥ 18mmHg | ||||
No | Reference | Reference | ||
Yes | 1.48 (1.14, 1.94) | 0.004 | 1.49 (1.18, 1.87) | <0.001 |
Missing | 1.21 (1.04, 1.41) | 0.02 | 1.13 (0.99, 1.30) | 0.07 |
Abbreviations:CI, confidence interval; CLD, chronic lung disease; ECMO, extracorporeal membrane oxygenation; LVAD, left ventricular assist device; SV, single ventricle; MV, mixed venous; MPA, main pulmonary artery; EDP, end diastolic pressure